News & Analysis on Clinical Trial Services & Contract Research And Development
Industry group the ABPI has called on the next UK Government to support local drug production, increase National Health Service (NHS) funding and put life sciences at the heart of its post-Brexit plan.
Catalent Pharma Solutions has said it will increase spray drying capacity at a plant owned by recent acquisition Pharmatek Laboratories.
Acasti Pharma Inc. has been granted two additional composition and use patents for its investigational, hypertriglyceridemia drug candidate CaPre.
H&T Presspart has bought the rights to manufacture and commercialise a capsule-based dry powder inhaler (DPI) from Hovione.
Catalent Pharma Solutions is increasing cGMP spray drying capacity at its Pharmatek facility in response to industry demand for improved solubility.
Recipharm has opened a new GMP suite for clinical trial material manufacture at its North Carolina-based facility in Research Triangle Park.